Horiana

What Horiana does

Horiana is a French health data consulting firm headquartered in Bordeaux with a regional office in San Francisco, operating as a SAS (Société par Actions Simplifiée) private company and positioned within the athagoras group. The company delivers professional services in biostatistics, epidemiology, evidence synthesis, and real-world evidence (RWE) generation for pharmaceutical and healthcare clients, with named enterprise engagements spanning Gilead Sciences, Pfizer, Bayer, Argenx, Nordic Pharma, Air Liquide, and Satelia.

Its core offerings cluster around three pillars: methodology and statistics (network meta-analyses, MAIC, cluster-randomization, predictive modeling for subgroup identification), External Comparator Arm / Synthetic Control Arm studies (propensity scores, instrumental variables, g-computation, quantitative benefit-risk assessment), and French nationwide database expertise across SNDS, PMSI, and ESND — a dataset covering 99% of the French population and gated by CESREES and CNIL approvals. The firm also designs multi-country RWE studies via a network of US and EU data partners, supports primary data collection (CRF, registries, ePRO), and runs Qualiopi-certified bespoke training programs. Educational content is published through Kézako webinars and RWE Vignettes on YouTube, in French with English subtitles.

Commercially, Horiana operates a sales-led, B2B professional services model. Engagements are project-based and quote-driven with no publicly disclosed pricing, and revenue is generated through direct consulting work rather than software or licensing. The company has 25 employees and no disclosed funding rounds, external investors, or revenue figures. Its distribution is direct enterprise sales into pharma and life sciences, supplemented by a content-driven inbound motion on LinkedIn and YouTube, with the San Francisco office extending reach into North American accounts.

Name

Horiana

Legal name

HORIANA

Website

https://horiana.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Horiana is a France-based health data consulting firm delivering biostatistics, epidemiology, and real-world evidence services to pharmaceutical and healthcare clients. It specializes in French nationwide database (SNDS/PMSI) studies, external comparator arms, and multi-country RWE, serving enterprises such as Gilead, Pfizer, and Bayer.

Ownership category

akta.pro rank

Product category

Health Data Consulting

NAICS

Other Scientific and Technical Consulting Services (541690), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industry

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM)

Keywords

• Health data consulting
• Real-world evidence
• Biostatistics services
• Epidemiology research
• Pharmaceutical analytics

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Consulting Services: Professional consulting services in health data analysis, biostatistics, and epidemiology. Revenue generated through project-based engagements with pharmaceutical companies and healthcare organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Horiana is a health data consulting firm that designs and executes biostatistics, epidemiology, evidence synthesis, external comparator arm studies, multi-country real-world studies, and primary and secondary data analyses for pharmaceutical, healthcare, and life sciences clients. It also provides bespoke Qualiopi-certified training in biostatistics and epidemiology. The firm differentiates through deep expertise in French nationwide claim databases (SNDS, PMSI, ESND) and advanced statistical methodologies such as cluster-randomization, MAIC, NMA, and synthetic control arms.

Product overview

Horiana is a health data consulting firm offering a unified portfolio of analytical services rather than discrete software products. Core offerings include biostatistics and machine learning consulting, epidemiology study design and execution, evidence synthesis (network meta-analyses and MAIC), external comparator arm studies, multi-country real-world studies, primary data collection (CRF, registries, ePRO), secondary database studies, SNDS/PMSI expertise (French nationwide health databases), and bespoke training programs. These services are interconnected, with the company providing end-to-end support from study design through execution and analysis, leveraging French health database expertise as a key differentiator.

Differentiator

Problem solved

Functional benefit

Products and services

• Biostatistics & Machine Learning Consulting Methodology and biostatistics consulting encompassing cluster-randomization to mitigate selection bias, predictive modeling for subgroup identification, and other cutting-edge machine learning approaches applied to health data. Targeted at pharmaceutical and healthcare clients needing advanced statistical design and analysis.
• Epidemiology Studies Design and execution of descriptive, comparative, or evaluative epidemiological studies using standard designs or advanced methodologies such as self-controlled designs and complex multivariate models. Targeted at pharmaceutical companies and healthcare organizations requiring precise epidemiological evidence.
• Evidence Synthesis Synthesis of clinical evidence across studies using network meta-analyses (NMA) and Matching-Adjusted Indirect Comparison (MAIC). Targeted at pharmaceutical clients comparing multiple treatments for regulatory and market access purposes.
• External Comparator Arm Studies Orchestration of Synthetic Control Arm studies using optimal data sources and advanced methodologies including propensity scores, instrumental variables, g-computation, and quantitative benefit-risk assessment. Targeted at pharmaceutical sponsors needing comparator evidence for single-arm trials.
• Multi-Country Real-World Studies Design and execution of international real-world studies through a network of data partners in the US and EU committed to scientific rigor and regulatory compliance. Targeted at pharmaceutical and life sciences clients needing cross-border observational evidence.
• Primary Data Collection Design and analysis of prospectively collected data including Case Report Forms (CRF), disease-specific registries, and electronic Patient Reported Outcomes (ePRO) with full project support. Targeted at pharmaceutical and healthcare clients running prospective clinical or observational studies.
• Secondary Database Studies Selection and leverage of relevant secondary databases to conduct real-world studies, with support through regulatory processes from database selection to study execution. Targeted at pharmaceutical and healthcare clients needing retrospective database analyses.
• SNDS / PMSI Expertise Extensive proficiency in leveraging the French nationwide claim databases (SNDS, PMSI, ESND) for studies on disease burden, patient pathways, health care resource utilization, and drug or medical device efficacy and safety. Targeted at pharmaceutical and healthcare clients with regulatory-grade French real-world data needs.
• Bespoke Training Programs Customized training in biostatistics and epidemiology adapted to client needs, ranging from brief overviews to comprehensive advanced courses, with Qualiopi certification. Targeted at pharmaceutical, healthcare, and life sciences teams seeking capability building.

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

One partnership is on record.

• athagorascoreStrategic or Co-development PartnerHoriana is part of athagoras group, indicating a strategic parent-subsidiary relationship within the health data consulting ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Clinerion: Emerging health data network operator providing access to hospital-based patient data for pharma RWE and clinical trial feasibility; comparable in using proprietary data assets to serve pharma RWE use cases, though with a different data-acquisition model.

Broad incumbents

• Evidera (PPD/Thermo Fisher): Large global RWE and health economics consulting arm serving top-20 pharma with RWE, HEOR, and market access; broader portfolio but directly overlapping in NMA, MAIC, and real-world evidence generation for pharma.
• IQVIA: Global CRO and RWE leader with extensive real-world data assets and biostatistics services for pharma; broad incumbent offering overlap with Horiana's RWE and epidemiology service line at much larger scale.
• ICON plc: Global CRO with PRA Health Sciences heritage providing RWE, HEOR, and biostatistics services to pharma; broad incumbent competing for the same enterprise RWE engagements as Horiana.

Direct peers

• Heva: French health data and RWE consulting firm with deep SNDS/PMSI expertise serving pharma clients on epidemiology and health economics studies; directly comparable in methodology, customer base, and geographic anchoring.
• Cytel: Global biostatistics and advanced analytics CRO serving pharma with NMA, MAIC, and Bayesian methods; comparable in evidence-synthesis and biostatistics service offerings and pharma customer base, though at larger scale.
• Cegedim Health Data: French health data solutions provider with proprietary access to French claims and EHR databases (THIN, Longitudinal Patient Database), serving pharmaceutical RWE needs; highly comparable in SNDS-adjacent data access and pharma customer base.
• Kappa Santé: French CRO specializing in pharmacoepidemiology, biostatistics, and clinical study management for pharma; comparable in offering portfolio, biostatistical methodology, and French pharma client base.
• Stève Consultants: French health data consultancy providing epidemiology, biostatistics, and SNDS studies to pharmaceutical and public-health clients; directly comparable in scope, methodology, and target customers.
• OpenHealth: French health data and epidemiology consultancy offering RWE, market access, and SNDS-based studies to pharma and medtech clients; comparable in service portfolio, methodology focus, and French-anchored customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/PLuX0JEZrr1w
• LinkedInlinkedin.com/company/horiana

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Horiana